Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, . Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development ...

Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement ...

If you are a healthcare professional or a patient seeking to report an adverse event, please call 1-800-265-7927 to speak with a Sanofi Medical Information agent or click here to visit Sanofi Medical ...

Sanofi in discussions to sell a controlling stake in Opella Paris, . Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of ...

헬스케어 분야에서 미충족 수요가 있는 곳에 교육 및 의약품 접근성 향상, 질환인식개선을 위해 노력합니다. 이를 위해 환자를 Care하며, 건강을 Protect하고, 사회를 Engage하는 사회책임활동을 수행합니다. 만성질환, 희귀질환, 암 환아 및 청소년, 생존자 및 가족을 ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, . Sanofi advances its ambition to protect ...

이전에 2차 이상의 전신 요법에 실패한 만성 이식편대숙주 질환이 있는 성인 및 12세 이상의 소아 환자의 치료 ...

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session. Third quarter 2025 results will ...

Sanofi’s commitment to society is long-term, and a longstanding legacy. Our commitment translates into a set of actions to make a positive impact on the lives of people and communities around the ...

Samarbete mellan industri och vårdpersonal gynnar patienterna. Det är en relation som har resulterat i många innovativa mediciner och som har förändrat hur flertalet sjukdomar påverkar våra liv. 1 ...

100% of developing countries work towards the UNFCCC goal of having their NAPs in place by 2025, with all new NAPs including specific health targets reflecting national and sub-national priorities.

100 % des pays en développement œuvrent pour atteindre l'objectif de la CCNUCC d'avoir leurs PNA (Plans nationaux d'adaptation) en place d'ici 2025, avec l'inclusion dans chaque nouveau PNA ...